ibhf fellows
Stuart A. Newman, Ph.D.
Fellow
Stuart A. Newman is Professor of Cell Biology and Anatomy at
New York Medical College, where he directs a research program
in developmental biology. He has contributed to several scientific
fields, including cell differentiation, theory of biochemical
networks and cell pattern formation, protein folding and assembly,
and mechanisms of morphological evolution. He was a founding member
of the Council for Responsible Genetics and has testified before
Congressional committees on issues ranging from patenting of organisms
to human stem cells and cloning. He has also been a consultant
to the National Institutes of Health on policy regarding the use
of human fetal tissue for research. In response to the growth
in patenting of life forms and the emergence of technologies that
threaten to blur the boundary between human and nonhuman organisms,
Dr. Newman applied for a patent on human-chimp chimeras (mixed
species organisms) as a challenge to existing patent policy, and
a way to prevent inappropriate uses of the technology.
Online Articles
The Hazards of Human Developmental Gene Modification
Council for Responsible Genetics website
http://www.gene-watch.org/programs/cloning/hazards.html.
Yuppie Eugenics - Creating a world with genetic haves and have–nots
Z Magazine Online website
http://www.zmag.org/ZMag/articles/march02hubbard-newman.htm
(with Ruth Hubbard)
Don't Try To Engineer Human Embryos
Council for Responsible Genetics website
http://www.gene-watch.org/programs/cloning/don%27t-engineer.html.
Ban Human Cloning Right Now
Center for Genetics and Society website
http://www.genetics-and-society.org/resources/items/20010803_globe_norsigian.html
(with Judy Norsigian) (August 3, 2001).
Testimony
Prepared Witness Testimony
The Committee on Energy and Commerce
H.R. 1644, Human Cloning Prohibition Act of 2001, and H.R.____,
Cloning Prohibition Act of 2001
Subcommittee on Health
June 20, 2001
10:15 AM
2123 Rayburn House Office Building
Prepared Witness Testimony
Hearing on human cloning
U.S. Senate Committee on Health, Education, Labor and Pensions
March 5, 2002
| 
